Medipal Holdings (TSE:7459) GF Value Rank: 9 (As of Aug. 07, 2026) — 13% Above Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:7459 Medipal Holdings Corp TSE:7459
83 GF Score
Price 円2,801.00
GF Value 円2,737.56
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Medipal Holdings GF Value Rank?

Medipal Holdings TSE:7459 +3.22% 83 GF Value Rank is 9 as of Aug. 07, 2026, which is 13% above its 10-year median of 8.00. GuruFocus rates TSE:7459 with a GF Score™ of 83/100 and a GF Value™ of 円2,737.56 (Fairly Valued). The stock has 6 warning signs investors should review.

Medipal Holdings has the GF Value Rank of 9.

GF Value Rank evaluates the exclusive GuruFocus valuation and performance of a stock, rated on a scale from 1 to 10. It is determined by the price-to-GF-Value (P/GF Value) ratio, a proprietary metric calculated based on historical multiples along with an adjustment factor based on a company's past returns and growth and future estimates of the business' performance.

GuruFocus found that for valuation, we cannot simply give stocks a better GF Value rank simply because they have a lower P/GF Value ratio. Backtesting shows that over the long term, the two worst-performing groups are the most expensive group (with the highest P/GF Value ratio) and the least expensive group (with the lowest P/GF Value ratio).

We can understand why the most expensive group underperforms. We were initially puzzled by the underperformance of the least expensive group, but we realized there is a reason why some stocks are super cheap. If they look too undervalued, it is often because the businesses behind them are poor quality. The market realized this and gave them low valuations. In a way, the market is efficient.

After multiple backtesting analyses, we granted the stocks in third-cheapest percentile the highest GF Value rank, as they have performed the best over a full market cycle. Stock performance is actually not as sensitive to valuation as it is to growth and profitability. On average, the companies in the 20%-50% valuation groups have similar performances. Therefore, we should avoid the most expensive and the least expensive stocks. We can be more tolerant of valuation.

A higher score indicates a stock with a relatively low valuation and substantial potential for outperformance. Conversely, a lower score often reflects stocks that are either highly overvalued or deeply undervalued, both of which tend to underperform.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.


Medipal Holdings GF Value Rank Related Terms


TSE:7459 vs MCK, COR, CAH: GF Value Rank Comparison

For the Medical Distribution subindustry, Medipal Holdings's GF Value Rank, along with its competitors' market caps and GF Value Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medipal Holdings GF Value Rank vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Medipal Holdings's GF Value Rank distribution charts can be found below:

* The bar in red indicates where Medipal Holdings's GF Value Rank falls into.


TSE:7459
83GF Score
Medipal Holdings Corp TSE:7459
GF Value Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about GF Value Rank →
What does a GF Value Rank of 9 mean?
Medipal Holdings (TSE:7459) has a GF Value Rank of 9 as of Aug. 07, 2026. GF Value Rank is given based on historical multiples along with past returns, growth and future estimates of the business' performance. View historical data on Medipal Holdings and its competitors. This is 13% above median its historical median of 8.00. Over the past decade, Medipal Holdings' GF Value Rank has ranged from 1.00 to 10.00.
Is Medipal Holdings' GF Value Rank too high?
Medipal Holdings' current GF Value Rank of 9 is 13% above median its 10-year median of 8.00. Over the past 10 years, this metric has ranged from a low of 1.00 to a high of 10.00. Overall, Medipal Holdings has a GF Score™ of 83/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Medipal Holdings' GF Value Rank compare to MCK and COR?
Medipal Holdings' GF Value Rank of 9 can be compared against companies in the Medical Distribution industry. Historically, Medipal Holdings' own GF Value Rank has ranged from 1.00 to 10.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good GF Value Rank for a Medical Distribution company?
A good GF Value Rank depends on the Medical Distribution industry context. However, GF Value Rank should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high GF Value Rank mean?
A high GF Value Rank can signal that a stock is expensive relative to its fundamentals. GF Value Rank is given based on historical multiples along with past returns, growth and future estimates of the business' performance. View historical data on Medipal Holdings and its competitors. Medipal Holdings's current GF Value Rank is 9, which is 13% above median its own 10-year median of 8.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medipal Holdings stock overvalued right now?
Based on GuruFocus' analysis, Medipal Holdings (TSE:7459) is currently considered Fairly Valued. The stock's GF Value™ is 円2,737.56, compared to a current price of 円2,801.00 — trading 2.3% above its estimated fair value. The current GF Value Rank is 9, which is 13% above median its 10-year median of 8.00. Medipal Holdings' overall GF Score™ is 83/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is GF Value Rank calculated?
GF Value Rank is calculated from a company's financial statements. For Medipal Holdings (TSE:7459), the current GF Value Rank is 9 as of Aug. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medipal Holdings (TSE:7459) Overvalued in 2026?

Based on GuruFocus' analysis, Medipal Holdings stock appears to be overvalued. The current stock price of 円2,801.00 is trading 2.3% above its estimated GF Value™ of 円2,737.56. GuruFocus considers Medipal Holdings to be Fairly Valued.

Key valuation signals for TSE:7459:

  • GF Value Rank: 9 (13% above median its 10-year median of 8.00)
  • GF Value™: 円2,737.56 vs. price of 円2,801.00 (2.3% above fair value)
  • GF Score™: 83/100 with 6 warning signs

No single metric tells the full story. See the TSE:7459 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Medipal Holdings Business Description

Other Exchanges MEPDF:USAMAHLY:USA
Address 3-1-1 Kyobashi, Chuo-ku, Tokyo, JPN, 104-8461
Medipal Holdings Corp is engaged in the wholesale distribution of pharmaceuticals, cosmetics, daily necessities, and related products. The company operates through three reportable segments: Wholesale business of medical drugs; Cosmetics, Daily Necessities and OTC Pharmaceuticals Wholesale Business; and Wholesale of animal medicines and food processing ingredients. The Wholesale business of medical drugs segment targets hospitals, clinics, and dispensing pharmacies; the Cosmetics and OTC segment serves drug stores, home centers, convenience stores, and supermarkets; while the Wholesale of animal medicines and food processing ingredients segment supplies veterinary clinics, livestock and fisheries businesses, and food manufacturers.
83GF Score

Get the complete analysis for TSE:7459

GF Value Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円2,801.00
Price
円2,737.56
GF Value